Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism

Author(s): Shyamal Palit, Jessica Kendrick.

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 37 , 2014

Become EABM
Become Reviewer

Abstract:

In patients with chronic kidney disease (CKD), vascular calcification is associated with significant morbidity and mortality. The prevalence of vascular calcification increases as glomerular filtration rate (GFR) declines and calcification occurs years earlier in CKD patients than in the general population. The mechanisms of vascular calcification in CKD patients are complex and not completely understood but likely involve non-traditional risk factors, which may be unique to patients with CKD. These unique risk factors may predispose patients to early and more accelerated calcification. Experimental and clinical studies show that disorders in mineral metabolisms including calcium and phosphorus homeostasis initiate and promote vascular calcification in patients with CKD. It is currently unknown if vascular calcification can be prevented or reversed with therapies aimed at maintaining calcium and phosphorus homeostasis. This review focuses on the potential mechanisms by which disordered mineral metabolism may promote vascular calcification in patients with CKD.

Keywords: Vascular calcification, chronic kidney disease, mineral metabolism, phosphorus.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 20
ISSUE: 37
Year: 2014
Page: [5829 - 5833]
Pages: 5
DOI: 10.2174/1381612820666140212194926
Price: $58

Article Metrics

PDF: 23